Outcomes for liver transplant candidates listed with low model for end-stage liver disease score

被引:39
作者
Kwong, Allison J. [1 ]
Lai, Jennifer C. [3 ]
Dodge, Jennifer L. [2 ]
Roberts, John P. [2 ]
机构
[1] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA
关键词
HIGH-RISK; MORTALITY; CIRRHOSIS; DEATH; MELD; PREDICTION; ALLOCATION; ASCITES;
D O I
10.1002/lt.24307
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The Model for End-Stage Liver Disease (MELD) score, which estimates mortality within 90 days, determines priority for liver transplantation (LT). However, longer-term outcomes on the wait list for patients who are initially listed with low MELD scores are not well characterized. All adults listed for primary LT at a single, high-volume center from 2005 to 2012 with an initial laboratory MELD score of 22 or lower were evaluated. Excluded were those patients listed with MELD exception points who underwent living donor liver transplantation (LDLT) or transplantation at another center, or who were removed from the wait list for nonmedical reasons. Outcomes and causes of death were identified by United Network for Organ Sharing, the National Death Index, and an electronic medical record review. Multivariate competing risk analysis evaluated predictors of death compared to deceased donor liver transplantation (DDLT); 893 patients were listed from 2005 to 2012. By the end of follow-up, 27% had undergone DDLT, and 31% were removed from the wait list for death or clinical deterioration. In a competing risks assessment, only MELD score of 6-9, older age, lower serum albumin, lower body mass index, and diabetes conferred an increased risk of wait-list dropout compared to DDLT. Listing for simultaneous liver-kidney transplantation was protective against wait-list dropout. Of the patients included, 275 patients died or were delisted for being too sick; 87% of the identifiable causes of death were directly related to end-stage liver disease or hepatocellular carcinoma. In conclusion, patients with low listing MELD scores remain at a significant risk for death due to liver-related causes and may benefit from early access to transplantation, such as LDLT or acceptance of high-risk donor livers. Predictors of death compared to transplantation may allow for early identification of patients who are at risk for wait-list mortality. Liver Transpl 21:1403-1409, 2015. (c) 2015 AASLD.
引用
收藏
页码:1403 / 1409
页数:7
相关论文
共 50 条
[41]   Model for end-stage liver disease score predicts complications after liver transplantation [J].
Pommergaard, Hans-Christian ;
Daugaard, Thomas Rojkjaer ;
Rostved, Andreas Arendtsen ;
Schultz, Nicolai Aagaard ;
Hillingso, Jens ;
Krohn, Paul Suno ;
Rasmussen, Allan .
LANGENBECKS ARCHIVES OF SURGERY, 2021, 406 (01) :55-65
[42]   Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea [J].
Kim, Jeong Han ;
Cho, Yong Joon ;
Choe, Won Hyeok ;
Kwon, So Young ;
Yoo, Byung-Chul .
KOREAN JOURNAL OF INTERNAL MEDICINE, 2024, 39 (02) :248-260
[43]   Impact of the Model for End-Stage Liver Disease (MELD) Score on Liver Transplantation in Greece [J].
Karapanagiotou, A. ;
Kydona, C. ;
Dimitriadis, C. ;
Papadopoulos, S. ;
Theodoridou, T. ;
Tholioti, T. ;
Fouzas, G. ;
Imvrios, G. ;
Gritsi-Gerogianni, N. .
TRANSPLANTATION PROCEEDINGS, 2014, 46 (09) :3212-3215
[44]   Sluggish decline in a post-transplant model for end-stage liver disease score is a predictor of mortality in living donor liver transplantation [J].
Hwang, Won Jung ;
Jeon, Joon Pyo ;
Kang, Seung Hee ;
Chung, Hyun Sik ;
Kim, Ji Yong ;
Park, Chul Soo .
KOREAN JOURNAL OF ANESTHESIOLOGY, 2010, 59 (03) :160-166
[45]   LIVING DONOR LIVER TRANSPLANTATION IN HIGH MODEL FOR END-STAGE LIVER DISEASE SCORE [J].
Dayangac, M. ;
Akyildiz, M. ;
Gungor, G. ;
Erdogan, Y. ;
Tokat, Y. .
TRANSPLANT INTERNATIONAL, 2014, 27 :22-23
[46]   Model for End-Stage Liver Disease score predicts mortality in critically ill cirrhotic patients [J].
Boone, M. Dustin ;
Celi, Leo A. ;
Ho, Ben G. ;
Pencina, Michael ;
Curry, Michael P. ;
Lior, Yotam ;
Talmor, Daniel ;
Novack, Victor .
JOURNAL OF CRITICAL CARE, 2014, 29 (05) :881.e7-881.e13
[47]   Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis [J].
Sheng, Qin-Song ;
Lang, Ren ;
He, Qiang ;
Yang, Yong-Jiu ;
Zhao, De-Fang ;
Chen, Da-Zhi .
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2009, 8 (01) :46-49
[48]   Aetiology of cirrhosis of the liver has an impact on survival predicted by the Model of End-stage Liver Disease score [J].
Angermayr, B. ;
Luca, A. ;
Konig, F. ;
Bertolini, G. ;
Ploner, M. ;
Gridelli, B. ;
Ulbrich, G. ;
Reiberger, T. ;
Bosch, J. ;
Peck-Radosavljevic, M. .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2009, 39 (01) :65-71
[49]   Assessment of short-term survival after liver transplant by the model for end-stage liver disease [J].
Buenadicha, AL ;
Martín, LG ;
Martín, EE ;
Pajares, A ;
Pérez, AM ;
Seral, CC ;
Marugán, RB .
TRANSPLANTATION PROCEEDINGS, 2005, 37 (09) :3881-3883
[50]   Refitting the Model for End-Stage Liver Disease for the Eurotransplant Region [J].
Goudsmit, Ben F. J. ;
Putter, Hein ;
Tushuizen, Maarten E. ;
Vogelaar, Serge ;
Pirenne, Jacques ;
Alwayn, Ian P. J. ;
van Hoek, Bart ;
Braat, Andries E. .
HEPATOLOGY, 2021, 74 (01) :351-363